Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?

Eur Respir J. 2012 Oct;40(4):1051-3. doi: 10.1183/09031936.00202411.
No abstract available

MeSH terms

  • Adult
  • Anti-Infective Agents / pharmacokinetics*
  • Aza Compounds / pharmacokinetics*
  • Chromatography, High Pressure Liquid
  • Drug Monitoring
  • Female
  • Fluoroquinolones
  • Humans
  • Male
  • Middle Aged
  • Moxifloxacin
  • Pilot Projects
  • Prospective Studies
  • Quinolines / pharmacokinetics*
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin